Cargando…

Cinacalcet: the chemical parathyroidectomy?

Detalles Bibliográficos
Autores principales:	Bellasi, Antonio, Cozzolino, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400481/ https://www.ncbi.nlm.nih.gov/pubmed/26064483 http://dx.doi.org/10.1093/ckj/sft036

Ejemplares similares

Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis
por: Dulfer, R. R., et al.
Publicado: (2019)

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Alvarado, Luis, et al.
Publicado: (2022)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
por: Elhadedy, Muhammed Ahmed, et al.
Publicado: (2023)

Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
por: Patel, Rima, et al.
Publicado: (2020)

Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy
por: Rivelli, Gabriel Giollo, et al.
Publicado: (2020)

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study
por: Jung, Suyun, et al.
Publicado: (2022)

Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease
por: Konstantinidis, Ioannis, et al.
Publicado: (2013)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
por: Zitt, Emanuel, et al.
Publicado: (2013)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene
por: Çömlek, Fatma Özgüç, et al.
Publicado: (2022)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
por: Roggeri, Alessandro, et al.
Publicado: (2020)

Vitamin D: something new under the sun
por: Cozzolino, Mario
Publicado: (2012)

Magnesium: a renewed player of vascular ageing in diabetic CKD patients?
por: Galassi, Andrea, et al.
Publicado: (2014)

A roadmap to parathyroidectomy for kidney transplant candidates
por: Cianciolo, Giuseppe, et al.
Publicado: (2022)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Cinacalcet in HIV haemodialysis patients
por: Belmouaz, Simohamed, et al.
Publicado: (2008)

Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017)

Comparing subtotal parathyroidectomy and total parathyroidectomy with autotransplantation in renal transplant recipients
por: Black, Katherine A., et al.
Publicado: (2023)

Erratum to: A roadmap to parathyroidectomy for kidney transplant candidates
por: Cianciolo, Giuseppe, et al.
Publicado: (2022)

A Comparison of Minimally Invasive Video-Assisted Parathyroidectomy and Traditional Parathyroidectomy for Parathyroid Adenoma
por: Rio, Paolo Del, et al.
Publicado: (2013)

Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia
por: Sethi, Bipin Kumar, et al.
Publicado: (2017)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
por: Jeong, Sohyun, et al.
Publicado: (2016)

Effects of cinacalcet treatment on QT interval in hemodialysis patients
por: Temiz, Gökhan, et al.
Publicado: (2016)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study
por: Ketteler, Markus, et al.
Publicado: (2012)

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
por: Wheeler, David C., et al.
Publicado: (2014)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

A novel asymmetric synthesis of cinacalcet hydrochloride
por: Arava, Veera R, et al.
Publicado: (2012)

The effects of discontinuing cinacalcet at the time of kidney transplantation
por: Jadoul, Michel, et al.
Publicado: (2010)

Cinacalcet: A Viable Therapeutic Option for Primary Hyperparathyroidism in the Elderly
por: Abusahmin, Hussam, et al.
Publicado: (2018)

Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
por: Warady, Bradley A., et al.
Publicado: (2020)

Pharmacogenetic and safety analysis of cinacalcet hydrochloride in healthy Chinese subjects
por: Liu, Yang-Jie, et al.
Publicado: (2020)

Minimally Invasive Parathyroidectomy
por: Starker, Lee F., et al.
Publicado: (2011)

Effect of curative parathyroidectomy on insulin resistance
por: Putnam, Rachel, et al.
Publicado: (2016)

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
por: Ketteler, Markus, et al.
Publicado: (2012)

Catalysis as a Chemical, Physiological, and Pathological Process
por: Reid, John
Publicado: (1864)

Cinacalcet use in pediatric chronic kidney disease: A survey study
por: Al-Ahmed, Rafif A., et al.
Publicado: (2020)

Comparison of AMG 416 and cinacalcet in rodent models of uremia
por: Walter, Sarah, et al.
Publicado: (2014)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ieb8rf7df2q3k4u8laedjfg65g